This article will summarize the key results presented at ASH 2018 in the field of essential thrombocytopenia, polycythemia vera, myelofibrosis and rare myeproliferative neoplasms. In addition to this several interesting abstracts in the field of chronic myeloid leukemia are addressed (a more complete overview of CML highlights is given in another article in this BJH special).

(BELG J HEMATOL 2019;10(1):49–56)